Hemoptysis Resolution with Rituximab in Behç, et's Disease: A Case Report

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JAMAATI HAMIDREZA; ESKANDARI RAHA; SHARIF KASHANI BABAK; HAGHGOO ROODABEH; DASTAN FARZANEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: TANAFFOS Year:2022 | Volume:21 | Issue:3 Page(s): 401-404

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Hemoptysis Resolution with Rituximab in Behç, et's Disease: A Case Report

Author(s)

Keywords

Behç

et's disease

Hemoptysis

Refractory cases

Rituximab

Vasculitis

Abstract

Behç, et's disease (BD) is a multisystem, progressive, and inflammatory disorder of unknown etiology. Vasculitis is believed to underlie various clinical manifestations of BD and is known to be one of the main causes of death due to BD, in cases of large vessel involvement. The current study is done in order to examine the effects of Rituximab on the patient’, s debilitating clinical manifestations, as a result of not responding to the standard treatment regimens. The present case is a 28-year-old female patient with BD associated Vasculitis. She was referred to the respiratory referral center, chiefly complaining of intermittent episodes of massive Hemoptysis. She had also recurrent oral and genital ulcers, and difficulty in walking, despite considering the common treatment approaches for BD. Our patient received two courses of Rituximab in combination with intravenous methylprednisolone. Over six months follow-up period from the date of treatment initiation with Rituximab, symptoms of BD such as recurrent Hemoptysis and aphthous ulcers were reduced in both frequency and severity. Lower limb weakness and difficulty in walking were improved as well. To summarize, Rituximab appears to be an effective alternative for treatment-resistant Vasculitis in BD patients.

Cites

No record.

References

No record.

Cite

APA: Copy

JAMAATI, HAMIDREZA, ESKANDARI, RAHA, & HAGHGOO, ROODABEH. (2022). Hemoptysis Resolution with Rituximab in Behç, et's Disease: A Case Report. TANAFFOS, 21(3), 401-404. SID. https://sid.ir/paper/1078871/en

Vancouver: Copy

JAMAATI HAMIDREZA, ESKANDARI RAHA, HAGHGOO ROODABEH. Hemoptysis Resolution with Rituximab in Behç, et's Disease: A Case Report. TANAFFOS[Internet]. 2022;21(3):401-404. Available from: https://sid.ir/paper/1078871/en

IEEE: Copy

HAMIDREZA JAMAATI, RAHA ESKANDARI, and ROODABEH HAGHGOO, “Hemoptysis Resolution with Rituximab in Behç, et's Disease: A Case Report,” TANAFFOS, vol. 21, no. 3, pp. 401–404, 2022, [Online]. Available: https://sid.ir/paper/1078871/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops